Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Ras signaling pathway,0.015683432439387506,6.231892878880098,25.894452079022578,"['FLT1', 'RASAL3', 'RASGRP3']",0.26000972023473745,0,0,3
2,Rheumatoid arthritis,0.019245838507554087,10.25297619047619,40.50397665889558,"['FLT1', 'IL15']",0.26000972023473745,0,0,2
3,GABAergic synapse,0.023565402270941217,9.15558510638298,34.314910022432834,"['CACNA1A', 'SLC38A2']",0.26000972023473745,0,0,2
4,MAPK signaling pathway,0.032444519464382066,4.660947151681538,15.978769684643616,"['FLT1', 'CACNA1A', 'RASGRP3']",0.26000972023473745,0,0,3
5,Glutamatergic synapse,0.03860848109853757,6.925403225806452,22.53722412630091,"['CACNA1A', 'SLC38A2']",0.26000972023473745,0,0,2
6,Pantothenate and CoA biosynthesis,0.04310378091088633,26.227272727272727,82.46233691025404,['DPYD'],0.26000972023473745,0,0,1
7,beta-Alanine metabolism,0.04310378091088633,26.227272727272727,82.46233691025404,['DPYD'],0.26000972023473745,0,0,1
8,HIF-1 signaling pathway,0.04425697365697659,6.4039179104477615,19.96576590355697,"['FLT1', 'SERPINE1']",0.26000972023473745,0,0,2
9,Calcium signaling pathway,0.055139811258933344,5.6381578947368425,16.338723585258087,"['FLT1', 'CACNA1A']",0.2703322350599898,0,0,2
10,Intestinal immune network for IgA production,0.07990025306561949,13.098484848484848,33.099560240148634,['IL15'],0.2703322350599898,0,0,1
11,Taste transduction,0.07990025306561949,13.098484848484848,33.099560240148634,['CACNA1A'],0.2703322350599898,0,0,1
12,Protein digestion and absorption,0.07990025306561949,13.098484848484848,33.099560240148634,['SLC38A2'],0.2703322350599898,0,0,1
13,Nicotine addiction,0.08440209996346044,12.32620320855615,30.4723834608399,['CACNA1A'],0.2703322350599898,0,0,1
14,Rap1 signaling pathway,0.09248509858884417,4.143810679611651,9.865202173701375,"['FLT1', 'RASGRP3']",0.2703322350599898,0,0,2
15,Drug metabolism,0.09334174747124216,11.025518341307816,26.146882423258067,['DPYD'],0.2703322350599898,0,0,1
16,Complement and coagulation cascades,0.09777974459616653,10.472727272727273,24.349487132791978,['SERPINE1'],0.2703322350599898,0,0,1
17,Pyrimidine metabolism,0.09777974459616653,10.472727272727273,24.349487132791978,['DPYD'],0.2703322350599898,0,0,1
18,Type II diabetes mellitus,0.11096759924278206,9.102766798418973,20.012587726259454,['CACNA1A'],0.28974873135615314,0,0,1
19,p53 signaling pathway,0.1535896829846658,6.335169880624426,11.86875469849703,['SERPINE1'],0.37993237369891014,0,0,1
20,Long-term depression,0.17415022578667663,5.497607655502392,9.608921992957002,['CACNA1A'],0.38153569584066716,0,0,1
21,Inflammatory mediator regulation of TRP channels,0.18223798653792744,5.221212121212122,8.888809906724514,['PRKCH'],0.38153569584066716,0,0,1
22,Serotonergic synapse,0.1981835229755549,4.743801652892562,7.678136113041459,['CACNA1A'],0.38153569584066716,0,0,1
23,Cytokine-cytokine receptor interaction,0.20604271068011895,4.536231884057971,7.165757577725426,['IL15'],0.38153569584066716,0,0,1
24,Synaptic vesicle cycle,0.21382710885467326,4.345959595959596,6.704022917974389,['CACNA1A'],0.38153569584066716,0,0,1
25,AGE-RAGE signaling pathway in diabetic complications,0.21769147784451334,4.256648113790971,6.490011168386241,['SERPINE1'],0.38153569584066716,0,0,1
26,B cell receptor signaling pathway,0.21769147784451334,4.256648113790971,6.490011168386241,['RASGRP3'],0.38153569584066716,0,0,1
27,Morphine addiction,0.2215374078465745,4.170909090909091,6.286243276546688,['CACNA1A'],0.38153569584066716,0,0,1
28,TNF signaling pathway,0.232965415291267,3.9331046312178386,5.730003535226719,['IL15'],0.38153569584066716,0,0,1
29,Vascular smooth muscle contraction,0.24423052073069026,3.720779220779221,5.244969425381011,['PRKCH'],0.38153569584066716,0,0,1
30,Chagas disease,0.24794974568370487,3.654970760233918,5.096963420041088,['SERPINE1'],0.38153569584066716,0,0,1
31,Cell adhesion molecules,0.251651203639589,3.5914315569487982,4.955138568627882,['ALCAM'],0.38153569584066716,0,0,1
32,JAK-STAT signaling pathway,0.26264979684503065,3.4133134624937904,4.563373813957231,['IL15'],0.3830096375253642,0,0,1
33,Cholinergic synapse,0.26989485662988183,3.303992303992304,4.327314103491123,['CACNA1A'],0.3830096375253642,0,0,1
34,Hippo signaling pathway,0.27707080161409325,3.2013986013986013,4.108938132678736,['SERPINE1'],0.3830096375253642,0,0,1
35,Pathways in cancer,0.29728391871425136,1.8979072398190044,2.302289859281917,"['IL15', 'RASGRP3']",0.38581953357714266,0,0,2
36,Apelin signaling pathway,0.3085242712761252,2.808353808353808,3.302497038825321,['SERPINE1'],0.38581953357714266,0,0,1
37,Transcriptional misregulation in cancer,0.3320657789240068,2.5630377852600077,2.8255497549384914,['FLT1'],0.38581953357714266,0,0,1
38,Chemical carcinogenesis,0.3353646933234224,2.531411677753141,2.765660167097733,['CACNA1A'],0.38581953357714266,0,0,1
39,Dopaminergic synapse,0.33864779135724477,2.5005476451259585,2.707579675342289,['CACNA1A'],0.38581953357714266,0,0,1
40,MicroRNAs in cancer,0.33864779135724477,2.5005476451259585,2.707579675342289,['FOXP1'],0.38581953357714266,0,0,1
41,Cellular senescence,0.35482859819332285,2.3567493112947657,2.441876105327629,['SERPINE1'],0.38581953357714266,0,0,1
42,Axon guidance,0.36119275483817614,2.303703703703704,2.345961729977177,['UNC5B'],0.38581953357714266,0,0,1
43,Focal adhesion,0.36119275483817614,2.303703703703704,2.345961729977177,['FLT1'],0.38581953357714266,0,0,1
44,Retrograde endocannabinoid signaling,0.36119275483817614,2.303703703703704,2.345961729977177,['CACNA1A'],0.38581953357714266,0,0,1
45,Spinocerebellar ataxia,0.3768377304648109,2.180861244019139,2.128391047062534,['CACNA1A'],0.39358607404102475,0,0,1
46,Human T-cell leukemia virus 1 infection,0.4711527987864182,1.6107954545454546,1.2122408841412544,['IL15'],0.4813952509339491,0,0,1
47,PI3K-Akt signaling pathway,0.4918399943328357,1.514260249554367,1.0745218444136553,['FLT1'],0.4918399943328357,0,0,1
